Literature DB >> 24958819

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

D Williams Parsons1, Angshumoy Roy2, Sharon E Plon2, Sameek Roychowdhury3, Arul M Chinnaiyan4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24958819      PMCID： PMC4188159          DOI： 10.1200/JCO.2013.54.8917

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

Review 1.  Return of individual research results and incidental findings: facing the challenges of translational science.

Authors:  Susan M Wolf
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

2.  Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

Authors:  David S Rosenblatt
Journal:  Mol Genet Metab       Date:  2013-06-07       Impact factor: 4.797

3.  BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

Authors:  Noralane M Lindor; David E Goldgar; Sean V Tavtigian; Sharon E Plon; Fergus J Couch
Journal:  Oncologist       Date:  2013-04-24

Review 4.  Genomics-driven oncology: framework for an emerging paradigm.

Authors:  Levi A Garraway
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

5.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

6.  Revealing the incidentalome when targeting the tumor genome.

Authors:  Yvonne Bombard; Mark Robson; Kenneth Offit
Journal:  JAMA       Date:  2013-08-28       Impact factor: 56.272

7.  Points to consider in the clinical application of genomic sequencing.

Authors: 
Journal:  Genet Med       Date:  2012-08       Impact factor: 8.822

Review 8.  Recommendations for returning genomic incidental findings? We need to talk!

Authors:  Wylie Burke; Armand H Matheny Antommaria; Robin Bennett; Jeffrey Botkin; Ellen Wright Clayton; Gail E Henderson; Ingrid A Holm; Gail P Jarvik; Muin J Khoury; Bartha Maria Knoppers; Nancy A Press; Lainie Friedman Ross; Mark A Rothstein; Howard Saal; Wendy R Uhlmann; Benjamin Wilfond; Susan M Wolf; Ron Zimmern
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

9.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

10.  Technical report: Ethical and policy issues in genetic testing and screening of children.

Authors:  Lainie Friedman Ross; Laine Friedman Ross; Howard M Saal; Karen L David; Rebecca R Anderson
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822
View more
  20 in total

1.  The Case for Universal Testing of Colorectal Tumors for Microsatellite Instability: A Coming Mismatch Between Clinical and Laboratory Testing.

Authors:  Patrick M Lynch
Journal:  Dig Dis Sci       Date:  2015-08       Impact factor: 3.199

2.  Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.

Authors:  Jada G Hamilton; Elyse Shuk; Margaux C Genoff; Vivian M Rodríguez; Jennifer L Hay; Kenneth Offit; Mark E Robson
Journal:  J Oncol Pract       Date:  2017-06-19       Impact factor: 3.840

Review 3.  Precision medicine in pediatric oncology: Lessons learned and next steps.

Authors:  Rajen J Mody; John R Prensner; Jessica Everett; D Williams Parsons; Arul M Chinnaiyan
Journal:  Pediatr Blood Cancer       Date:  2016-10-17       Impact factor: 3.167

4.  Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.

Authors:  Bryce A Seifert; Julianne M O'Daniel; Krunal Amin; Daniel S Marchuk; Nirali M Patel; Joel S Parker; Alan P Hoyle; Lisle E Mose; Andrew Marron; Michele C Hayward; Christopher Bizon; Kirk C Wilhelmsen; James P Evans; H Shelton Earp; Norman E Sharpless; D Neil Hayes; Jonathan S Berg
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

5.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Authors:  Robert C Green; Katrina A B Goddard; Gail P Jarvik; Laura M Amendola; Paul S Appelbaum; Jonathan S Berg; Barbara A Bernhardt; Leslie G Biesecker; Sawona Biswas; Carrie L Blout; Kevin M Bowling; Kyle B Brothers; Wylie Burke; Charlisse F Caga-Anan; Arul M Chinnaiyan; Wendy K Chung; Ellen W Clayton; Gregory M Cooper; Kelly East; James P Evans; Stephanie M Fullerton; Levi A Garraway; Jeremy R Garrett; Stacy W Gray; Gail E Henderson; Lucia A Hindorff; Ingrid A Holm; Michelle Huckaby Lewis; Carolyn M Hutter; Pasi A Janne; Steven Joffe; David Kaufman; Bartha M Knoppers; Barbara A Koenig; Ian D Krantz; Teri A Manolio; Laurence McCullough; Jean McEwen; Amy McGuire; Donna Muzny; Richard M Myers; Deborah A Nickerson; Jeffrey Ou; Donald W Parsons; Gloria M Petersen; Sharon E Plon; Heidi L Rehm; J Scott Roberts; Dan Robinson; Joseph S Salama; Sarah Scollon; Richard R Sharp; Brian Shirts; Nancy B Spinner; Holly K Tabor; Peter Tarczy-Hornoch; David L Veenstra; Nikhil Wagle; Karen Weck; Benjamin S Wilfond; Kirk Wilhelmsen; Susan M Wolf; Julia Wynn; Joon-Ho Yu
Journal:  Am J Hum Genet       Date:  2016-05-12       Impact factor: 11.025

6.  Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.

Authors:  Daniel G Stover; Raquel E Reinbolt; Elizabeth J Adams; Sarah Asad; Katlyn Tolliver; Mahmoud Abdel-Rasoul; Cynthia D Timmers; Susan Gillespie; James L Chen; Siraj Mahamed Ali; Katharine A Collier; Mathew A Cherian; Anne M Noonan; Sagar Sardesai; Jeffrey VanDeusen; Robert Wesolowski; Nicole Williams; Clara N Lee; Charles L Shapiro; Erin R Macrae; Bhuvaneswari Ramaswamy; Maryam B Lustberg
Journal:  JCO Precis Oncol       Date:  2019-11-18

7.  Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.

Authors:  Jonathan M Marron; Steven G DuBois; Julia Glade Bender; AeRang Kim; Brian D Crompton; Stephanie C Meyer; Katherine A Janeway; Jennifer W Mack
Journal:  Pediatr Blood Cancer       Date:  2016-07-18       Impact factor: 3.167

8.  Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

Authors:  Kasmintan A Schrader; Donavan T Cheng; Vijai Joseph; Meera Prasad; Michael Walsh; Ahmet Zehir; Ai Ni; Tinu Thomas; Ryma Benayed; Asad Ashraf; Annie Lincoln; Maria Arcila; Zsofia Stadler; David Solit; David M Hyman; David Hyman; Liying Zhang; David Klimstra; Marc Ladanyi; Kenneth Offit; Michael Berger; Mark Robson
Journal:  JAMA Oncol       Date:  2016-01       Impact factor: 31.777

9.  Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced Cancers.

Authors:  Jada G Hamilton; Elyse Shuk; Margaux Genoff Garzon; Vivian M Rodríguez; Joy Westerman; Jennifer L Hay; Kenneth Offit; Mark E Robson
Journal:  JCO Precis Oncol       Date:  2017-12-21

10.  The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance.

Authors:  Elizabeth Varga; Elizabeth C Chao; Nicholas D Yeager
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.